Market leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
Expert views
Research article: Synthesis of Peptides by Reactive Extrusion. Application to the Continuous and Solventless Preparation of Aspartame.
25 Apr 2024 - The latest results from an innovative mechanochemical approach to continuous and solventless peptide synthesis. PolyPeptide is dedicated to applying relevant principles of green chemistry to mitigate […]
Read moreMedia releases
PolyPeptide announces results of the annual General Meeting 2024
10 Apr 2024 - Baar, 10 April 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced that the shareholders […]
Read more